ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

CADL Candel Therapeutics Inc

8,85
0,00 (0,00%)
07 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Candel Therapeutics Inc CADL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 8,85 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,85
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202414:00GLOBECandel Therapeutics Announces Upcoming Presentations at the..
11.4.202415:00GLOBECandel Therapeutics Receives FDA Orphan Drug Designation for..
09.4.202414:00GLOBECandel Therapeutics Presents Preclinical Data at AACR on..
04.4.202414:00GLOBECandel Therapeutics Announces Positive Interim Data from..
28.3.202421:05GLOBECandel Therapeutics Announces Oral Presentation During the..
28.3.202413:05GLOBECandel Therapeutics Reports Fourth Quarter and Full Year..
06.3.202414:00EDGAR2Form 8-K - Current report
05.3.202422:30GLOBECandel Therapeutics Announces an Upcoming Presentation at..
13.2.202415:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.2.202413:45EDGAR2Form 8-K - Current report
13.2.202413:30GLOBECAN-3110 Receives FDA Fast Track Designation for Treatment..
05.2.202414:00GLOBECandel Therapeutics Sets Path to Success: Recent..
19.1.202414:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
12.1.202422:30EDGAR2Form 8-K - Current report
03.1.202414:30EDGAR2Form 8-K - Current report
12.12.202314:58DJNCandel Therapeutics Shares Soar After FDA Fast Track of..
12.12.202314:30EDGAR2Form 8-K - Current report
12.12.202314:00GLOBECandel Therapeutics Receives FDA Fast Track Designation for..
30.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202315:00EDGAR2Form 8-K - Current report
28.11.202315:00GLOBECandel Therapeutics Announces Restructuring to Prioritize..
21.11.202323:00EDGAR2Form 8-K - Current report
09.11.202314:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:16EDGAR2Form 8-K - Current report
09.11.202314:00GLOBECandel Therapeutics Reports Third Quarter 2023 Financial..
06.11.202314:53EDGAR2Form 8-K - Current report
06.11.202314:15EDGAR2Form 8-K - Current report
04.11.202313:00GLOBECandel Therapeutics Presents Preclinical Data from its..
03.11.202317:00GLOBECandel Therapeutics Announces Initial Positive Interim Data..
18.10.202317:31EDGAR2Form 8-K - Current report
18.10.202317:00GLOBECandel Therapeutics Announces Nature Publication Showing..
27.9.202315:40GLOBECandel Therapeutics Announces Three Abstracts Accepted for..
26.9.202314:30EDGAR2Form 8-K - Current report
26.9.202314:00GLOBECandel Therapeutics Reports Encouraging Initial Survival..
06.9.202314:00GLOBECandel Therapeutics to Participate in the H.C. Wainwright..
10.8.202314:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:15EDGAR2Form 8-K - Current report
10.8.202314:00GLOBECandel Therapeutics Reports Second Quarter 2023 Financial..
02.8.202314:00GLOBECandel Therapeutics to Participate in the Canaccord Genuity..
29.6.202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202314:31EDGAR2Form 8-K - Current report
13.6.202314:00GLOBECandel Therapeutics Announces It Expects to Report Topline..
08.6.202314:00GLOBECandel Therapeutics Appoints Experienced Manufacturing..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock